Agency Forms Undergoing Paperwork Reduction Act Review, 18631-18632 [2016-07225]

Download as PDF 18631 Federal Register / Vol. 81, No. 62 / Thursday, March 31, 2016 / Notices distributed to individuals who have not completed the online version. The estimated number of respondents for the full web-based or paper questionnaire is 420 and the estimated burden per response is 15 minutes. Approximately six weeks after the second recruitment attempt, ACOG will distribute a short version of the questionnaire to any nonresponders. The estimated number of responses for the short version of the questionnaire is 180 and the estimated No information will be collected about individual patients. Survey administration and data management will be conducted by ACOG, and participation is voluntary. De-identified response data will be shared with CDC for analysis. Findings will be used to create recommendations for educational programs and patient care. There are no costs to participants other than their time. burden per response is 5 minutes. An overall 40% response rate is expected. The survey will collect information about provider attitudes and beliefs regarding maternal opioid use, their screening and referral practices for pregnant or postpartum patients, barriers to screening and treating pregnant and postpartum patients for opioid use, and resources that are needed to improve treatment and referral. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents OB/GYNs caring for pregnant women. Total ........................ Practice Patterns Pregnancy and Practice Patterns Pregnancy and 420 1 15/60 105 180 1 5/60 15 .............................................................................. ........................ ........................ ........................ 120 [FR Doc. 2016–07226 Filed 3–30–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30 Day–16–1074] Agency Forms Undergoing Paperwork Reduction Act Review mstockstill on DSK4VPTVN1PROD with NOTICES Total burden (in hours) Related to Opioid Use During Lactation. Related to Opioid Use During Lactation (short version). Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the VerDate Sep<11>2014 Average burden per response (in hours) Number of responses per respondent Number of respondents Form name 19:09 Mar 30, 2016 Jkt 238001 burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Colorectal Cancer Control Program (CRCCP) Monitoring Activities —Reinstatement with Change (OMB No. 0920–1074, exp. 12/31/2015) —National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC is requesting a reinstatement with change of the information collect PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 project assigned OMB Control Number 0920–1074, formerly entitled ‘‘Annual Survey of Colorectal Cancer Control Activities Conducted by States and Tribal Organizations.’’ In the previous OMB approval period, information collection consisted of an annual grantee survey. In the next OMB approval period, information collection will consist of a redesigned survey and a new clinic-level information collection. The number of respondents will increase and the total estimated annualized burden will increase. Among cancers that affect both men and women, colorectal cancer (CRC) is the second leading cause of death from cancer in the United States. CRC screening has been shown to reduce incidence of and death from the disease. Screening for CRC can detect disease early when treatment is more effective and prevent cancer by finding and removing precancerous polyps. Of individuals diagnosed with early stage CRC, more than 90% live five or more years. Despite strong evidence supporting screening, only 65% of adults currently report being up-to-date with CRC screening as recommended by the U.S. Preventive Services Task Force, with more than 22 million age-eligible adults estimated to be untested. To reduce CRC morbidity, mortality, and associated costs, use of CRC screening tests must be increased among ageeligible adults with the lowest CRC screening rates. CDC’s Colorectal Cancer Control Program (CRCCP) currently provides funding to 31 grantees under ‘‘Organized Approaches to Increase E:\FR\FM\31MRN1.SGM 31MRN1 18632 Federal Register / Vol. 81, No. 62 / Thursday, March 31, 2016 / Notices Colorectal Cancer Screening’’ (CDC– RFA–DP15–1502). CRCCP grantees include state governments or bona-fide agents, universities, and tribal organizations. The purpose of the new cooperative agreement program is to increase CRC screening rates among an applicant defined target population of persons 50–75 years of age within a partner health system serving a defined geographical area or disparate population. The CRCCP was significantly redesigned in 2015 and has two components. Under Component 1, all 31 CRCCP grantees receive funding to support partnerships with health systems to implement up to four priority evidence-based interventions (EBIs) described in the Guide to Community Preventive Services, as well as other supporting strategies. Grantees must implement at least two EBIs in each partnering health system. Under Component 2, 6 of the 31 CRCCP grantees will provide direct screening and follow-up clinical services for a limited number of individuals aged 50– 64 in the program’s priority population who are asymptomatic, at average risk for CRC, have inadequate or no health insurance for CRC screening, and are low income. Based on the redesigned CRCCP, the information collection plan has also been redesigned to address the two program components. The new cooperative agreement program (CDC– RFA–DP15–1502) requires that CDC monitor and evaluate the CRCCP and individual grantee performance using both process and outcome evaluation. Two forms are proposed. First, the CRCCP grantee survey was redesigned to align with new CRCCP goals. The grantee survey will be submitted to CDC annually. Second, CDC proposes to collect clinic-level information to assess changes in CDC’s primary outcome of interest, i.e., CRC screening rates within partner health systems. Each grantee will complete a clinic-level collection template once per year. All information will be reported to CDC electronically. The information collection will enable CDC to gauge progress in meeting CRCCP program goals and to monitor implementation activities, evaluate outcomes, and identify grantee technical assistance needs. In addition, findings will inform program improvement and help identify successful activities that need to be maintained, replicated, or expanded. OMB approval is requested for three years. Participation is required for CRCCP awardees. In the pilot test for the CRCCP annual grantee survey, the average time to complete the instrument was approximately 45 minutes. In the pilot test for the CRCCP clinic-level information collection, the average time to complete the instrument was approximately 30 minutes. CDC estimates an average of 12 responses per grantee annually to correspond with the number of health system partners. The total estimated annualized burden hours are 209. There are no costs to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Form name CRCCP Grantees ........................................... CRCCP Annual Grantee Survey .................... CRCCP Clinic-level Information Collection Template. Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–07225 Filed 3–30–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration mstockstill on DSK4VPTVN1PROD with NOTICES Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276–1243. VerDate Sep<11>2014 19:09 Mar 30, 2016 Jkt 238001 Project: Substance Abuse Prevention and Treatment Block Grant Synar Report Format, FFY 2017–2019—(OMB No. 0930–0222)—Revision Section 1926 of the Public Health Service Act [42 U.S.C. 300x–26] stipulates that funding Substance Abuse Prevention and Treatment Block Grant (SABG) agreements for alcohol and drug abuse programs for fiscal year 1994 and subsequent fiscal years require states to have in effect a law providing that it is unlawful for any manufacturer, retailer, or distributor of tobacco products to sell or distribute any such product to any individual under the age of 18. This section further requires that states conduct annual, random, unannounced inspections to ensure compliance with the law; that the state submit annually a report describing the results of the inspections, the activities carried out by the state to enforce the required law, the success the state has achieved in reducing the availability of tobacco products to individuals under the age of 18, and the strategies to be utilized by the state for enforcing such law during PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 Number of responses per respondent 31 31 1 12 Average burden per response (in hr) 45/60 30/60 the fiscal year for which the grant is sought. Before making an award to a State under the SABG, the Secretary must make a determination that the state has maintained compliance with these requirements. If a determination is made that the state is not in compliance, penalties shall be applied. Penalties ranged from 10 percent of the Block Grant in applicable year 1 (FFY 1997 SABG Applications) to 40 percent in applicable year 4 (FFY 2000 SABG Applications) and subsequent years. Respondents include the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, Palau, Micronesia, and the Marshall Islands. Regulations that implement this legislation are at 45 CFR 96.130, are approved by OMB under control number 0930–0163, and require that each state submit an annual Synar report to the Secretary describing their progress in complying with section 1926 of the PHS Act. The Synar report, due December 31 following the fiscal year E:\FR\FM\31MRN1.SGM 31MRN1

Agencies

[Federal Register Volume 81, Number 62 (Thursday, March 31, 2016)]
[Notices]
[Pages 18631-18632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07225]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 Day-16-1074]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

Colorectal Cancer Control Program (CRCCP) Monitoring Activities

--Reinstatement with Change (OMB No. 0920-1074, exp. 12/31/2015)
--National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is requesting a reinstatement with change of the information 
collect project assigned OMB Control Number 0920-1074, formerly 
entitled ``Annual Survey of Colorectal Cancer Control Activities 
Conducted by States and Tribal Organizations.'' In the previous OMB 
approval period, information collection consisted of an annual grantee 
survey. In the next OMB approval period, information collection will 
consist of a redesigned survey and a new clinic-level information 
collection. The number of respondents will increase and the total 
estimated annualized burden will increase.
    Among cancers that affect both men and women, colorectal cancer 
(CRC) is the second leading cause of death from cancer in the United 
States. CRC screening has been shown to reduce incidence of and death 
from the disease. Screening for CRC can detect disease early when 
treatment is more effective and prevent cancer by finding and removing 
precancerous polyps. Of individuals diagnosed with early stage CRC, 
more than 90% live five or more years. Despite strong evidence 
supporting screening, only 65% of adults currently report being up-to-
date with CRC screening as recommended by the U.S. Preventive Services 
Task Force, with more than 22 million age-eligible adults estimated to 
be untested. To reduce CRC morbidity, mortality, and associated costs, 
use of CRC screening tests must be increased among age-eligible adults 
with the lowest CRC screening rates.
    CDC's Colorectal Cancer Control Program (CRCCP) currently provides 
funding to 31 grantees under ``Organized Approaches to Increase

[[Page 18632]]

Colorectal Cancer Screening'' (CDC-RFA-DP15-1502). CRCCP grantees 
include state governments or bona-fide agents, universities, and tribal 
organizations. The purpose of the new cooperative agreement program is 
to increase CRC screening rates among an applicant defined target 
population of persons 50-75 years of age within a partner health system 
serving a defined geographical area or disparate population.
    The CRCCP was significantly redesigned in 2015 and has two 
components. Under Component 1, all 31 CRCCP grantees receive funding to 
support partnerships with health systems to implement up to four 
priority evidence-based interventions (EBIs) described in the Guide to 
Community Preventive Services, as well as other supporting strategies. 
Grantees must implement at least two EBIs in each partnering health 
system. Under Component 2, 6 of the 31 CRCCP grantees will provide 
direct screening and follow-up clinical services for a limited number 
of individuals aged 50-64 in the program's priority population who are 
asymptomatic, at average risk for CRC, have inadequate or no health 
insurance for CRC screening, and are low income.
    Based on the redesigned CRCCP, the information collection plan has 
also been redesigned to address the two program components. The new 
cooperative agreement program (CDC-RFA-DP15-1502) requires that CDC 
monitor and evaluate the CRCCP and individual grantee performance using 
both process and outcome evaluation. Two forms are proposed. First, the 
CRCCP grantee survey was redesigned to align with new CRCCP goals. The 
grantee survey will be submitted to CDC annually. Second, CDC proposes 
to collect clinic-level information to assess changes in CDC's primary 
outcome of interest, i.e., CRC screening rates within partner health 
systems. Each grantee will complete a clinic-level collection template 
once per year. All information will be reported to CDC electronically.
    The information collection will enable CDC to gauge progress in 
meeting CRCCP program goals and to monitor implementation activities, 
evaluate outcomes, and identify grantee technical assistance needs. In 
addition, findings will inform program improvement and help identify 
successful activities that need to be maintained, replicated, or 
expanded.
    OMB approval is requested for three years. Participation is 
required for CRCCP awardees. In the pilot test for the CRCCP annual 
grantee survey, the average time to complete the instrument was 
approximately 45 minutes. In the pilot test for the CRCCP clinic-level 
information collection, the average time to complete the instrument was 
approximately 30 minutes. CDC estimates an average of 12 responses per 
grantee annually to correspond with the number of health system 
partners. The total estimated annualized burden hours are 209. There 
are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondent                    Form name            Number of     responses per   per response
                                                                    respondents     respondent        (in hr)
----------------------------------------------------------------------------------------------------------------
CRCCP Grantees........................  CRCCP Annual Grantee                  31               1           45/60
                                         Survey.
                                        CRCCP Clinic-level                    31              12           30/60
                                         Information Collection
                                         Template.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-07225 Filed 3-30-16; 8:45 am]
BILLING CODE 4163-18-P